Clover Health Investments
CLOV
176 hedge funds and large institutions have $262M invested in Clover Health Investments in 2022 Q2 according to their latest regulatory filings, with 40 funds opening new positions, 53 increasing their positions, 35 reducing their positions, and 30 closing their positions.
95% more call options, than puts
Call options by funds: $13.5M | Put options by funds: $6.93M
51% more repeat investments, than reductions
Existing positions increased: 53 | Existing positions reduced: 35
33% more first-time investments, than exits
New positions opened: 40 | Existing positions closed: 30
5.96% more ownership
Funds ownership: 26.32% → 32.28% (+6%)
5% more funds holding
Funds holding: 168 → 176 (+8)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
31% less capital invested
Capital invested by funds: $378M → $262M (-$115M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$49.8M |
| 2 |
State Street
Boston,
Massachusetts
|
+$16M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$16M |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$9.7M |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$7.41M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
-$13.7M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$12.8M |
| 3 |
Two Sigma Investments
New York
|
-$7.11M |
| 4 |
HF
HRT Financial
New York
|
-$5.99M |
| 5 |
D.E. Shaw & Co
New York
|
-$5.7M |
CLOV Hedge Fund Activity: Q2 2022 in Review
176 of the 5,959 institutional investors tracked by Wall St. Rank reported a position in Clover Health Investments (CLOV) for Q2 2022, worth a combined $262M — down 31% from $378M a quarter earlier.
Buyers outnumbered sellers: 40 funds opened new CLOV positions and 30 closed out — a net gain of 10 holders — while 53 added to existing stakes and 35 trimmed.
The largest buyer was BlackRock, adding an estimated $49.8M. The largest seller was Baillie Gifford & Co, cutting an estimated $13.7M.
- 176 institutional investors held Clover Health Investments (CLOV) as of Q2 2022, up from 168 in Q1 2022.
- Funds reported $262M of Clover Health Investments stock for Q2 2022, down 31% quarter-over-quarter.
- 40 funds opened new Clover Health Investments positions in Q2 2022 and 30 closed out, a net change of +10 holders.
- The largest Clover Health Investments buyer in Q2 2022 was BlackRock, an estimated $49.8M added.
- The largest Clover Health Investments seller in Q2 2022 was Baillie Gifford & Co, an estimated $13.7M sold.
Based on aggregated 13F filings for Q2 2022.